Fabrice Antigny

4.4k total citations · 1 hit paper
84 papers, 2.9k citations indexed

About

Fabrice Antigny is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Fabrice Antigny has authored 84 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pulmonary and Respiratory Medicine, 28 papers in Cardiology and Cardiovascular Medicine and 21 papers in Molecular Biology. Recurrent topics in Fabrice Antigny's work include Pulmonary Hypertension Research and Treatments (50 papers), Ion Channels and Receptors (20 papers) and Cystic Fibrosis Research Advances (11 papers). Fabrice Antigny is often cited by papers focused on Pulmonary Hypertension Research and Treatments (50 papers), Ion Channels and Receptors (20 papers) and Cystic Fibrosis Research Advances (11 papers). Fabrice Antigny collaborates with scholars based in France, Switzerland and United States. Fabrice Antigny's co-authors include Marc Humbert, Frédéric Perros, Maud Frieden, Frédéric Becq, Clarisse Vandebrouck, Benoît Ranchoux, David Montani, Peter Dorfmüller, Jessica Sabourin and Gérald Simonneau and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Fabrice Antigny

79 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension

2015 437 citations Benoît Ranchoux, Fabrice Antigny et al. Circulation profile →

Peers

Fabrice Antigny

PRM

CCM

SURGE

Carmelle V. Remillard United States

Songwei Wu United States

Larissa Lipskaia France

Norimichi Koitabashi Japan

Robert F. Spurney United States

Björn Friedrich Germany

Ying Shen China

Mohammad Tauseef United States

Patrick Most Germany

Boris Manoury France

Carmelle V. Remillard United States

Fabrice Antigny

1.1k ×0.7

PRM

1.4k ×1.2

659 ×0.8

CCM

718 ×1.7

398 ×1.2

SURGE

Citations per year, relative to Fabrice Antigny Fabrice Antigny (= 1×) peers Carmelle V. Remillard

Countries citing papers authored by Fabrice Antigny

Since Specialization

Citations

This map shows the geographic impact of Fabrice Antigny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Antigny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Antigny more than expected).

Fields of papers citing papers by Fabrice Antigny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Antigny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Antigny. The network helps show where Fabrice Antigny may publish in the future.

Co-authorship network of co-authors of Fabrice Antigny

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Antigny. A scholar is included among the top collaborators of Fabrice Antigny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Antigny. Fabrice Antigny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sitbon, Olivier, Athénaïs Boucly, Jason Weatherald, et al.. (2025). Drugs targeting novel pathways in pulmonary arterial hypertension. European Respiratory Journal. 66(2). 2401830–2401830. 2 indexed citations

Dutheil, Mary, Gilles Carpentier, Jessica Sabourin, et al.. (2025). TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension. Respiratory Research. 26(1). 345–345.

Favrolt, Nicolas, Marie‐Camille Chaumais, Étienne-Marie Jutant, et al.. (2024). Association of Pulmonary Hypertension With Trastuzumab Emtansine. CHEST Journal. 167(5). 1468–1480. 2 indexed citations

Bogaard, Harm Jan, Mélanie Eyries, Olivier Meyrignac, et al.. (2024). Pulmonary vascular phenotype identified in patients withGDF2(BMP9) orBMP10variants: an international multicentre study. European Respiratory Journal. 63(4). 2301634–2301634. 9 indexed citations

Mendes‐Ferreira, Pedro, Rui Adão, Steeve Provencher, et al.. (2024). Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function. International Journal of Molecular Sciences. 25(15). 8054–8054. 4 indexed citations

Khouri, Charles, Xavier Jaïs, Laurent Savale, et al.. (2024). Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors. European Respiratory Journal. 63(6). 2302158–2302158. 7 indexed citations

Adão, Rui, Carmen Brás‐Silva, Mélanie Eyries, et al.. (2023). Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart. The Journal of Physiology. 601(17). 3717–3737. 5 indexed citations

Brás‐Silva, Carmen, et al.. (2022). Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension. Biomolecules. 12(4). 484–484. 18 indexed citations

Capuano, Véronique, Mary Dutheil, Angèle Boët, et al.. (2022). SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. 66(5). 539–554. 17 indexed citations

10.

Hautbergue, Thaïs, Fabrice Antigny, Angèle Boët, et al.. (2021). Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure. Cells. 10(6). 1559–1559. 18 indexed citations

11.

Lambert, Mélanie, Pedro Mendes‐Ferreira, Maria‐Rosa Ghigna, et al.. (2021). Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload. Cardiovascular Research. 117(12). 2474–2488. 24 indexed citations

12.

Antigny, Fabrice, Barbara Girerd, Marie‐Camille Chaumais, et al.. (2021). Sex and gender in pulmonary arterial hypertension. European Respiratory Review. 30(162). 200330–200330. 56 indexed citations

13.

Antigny, Fabrice, Olaf Mercier, Marc Humbert, & Jessica Sabourin. (2020). Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension. Archives of cardiovascular diseases. 113(1). 70–84. 20 indexed citations

14.

Boët, Angèle, Mélanie Lambert, Wendy K. Chung, et al.. (2020). SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension. Archives of Cardiovascular Diseases Supplements. 12(2-4). 214–214. 2 indexed citations

15.

Dumas, Sébastien J., Gilles Bru‐Mercier, Audrey Courboulin, et al.. (2018). NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension. Circulation. 137(22). 2371–2389. 80 indexed citations

16.

Ranchoux, Benoît, Fabrice Antigny, Catherine Rücker‐Martin, et al.. (2015). Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. Circulation. 131(11). 1006–1018. 437 indexed citations breakdown →

17.

Meloche, Jolyane, François Potus, Benoît Ranchoux, et al.. (2015). miR-223 reverses experimental pulmonary arterial hypertension. American Journal of Physiology-Cell Physiology. 309(6). C363–C372. 102 indexed citations

18.

Perros, Frédéric, Benoît Ranchoux, Mohamed Izikki, et al.. (2015). Nebivolol for Improving Endothelial Dysfunction, Pulmonary Vascular Remodeling, and Right Heart Function in Pulmonary Hypertension. Journal of the American College of Cardiology. 65(7). 668–680. 111 indexed citations

19.

Boucherat, Olivier, Sophie Chabot, Fabrice Antigny, et al.. (2015). Potassium channels in pulmonary arterial hypertension. European Respiratory Journal. 46(4). 1167–1177. 60 indexed citations

20.

Sabourin, Jessica, Fabrice Antigny, Elodie Robin, Maud Frieden, & Eric Raddatz. (2012). Activation of Transient Receptor Potential Canonical 3 (TRPC3)-mediated Ca2+ Entry by A1 Adenosine Receptor in Cardiomyocytes Disturbs Atrioventricular Conduction. Journal of Biological Chemistry. 287(32). 26688–26701. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact